During the 2 1/2 hour closing arguments in an ongoing opioid trial, brought by New York State and counties alleging the drugmaker Allergan flooded the state with opioids, the firm agreed to a $200 million settlement. The lawsuit was specifically against AbbVie Inc, a company that is part of Allergan,... Read More »
Endo Agrees to $35 Million Settlement in Opioid Lawsuit Filed by Tennessee Counties
Drugmaker Endo has agreed to pay $35 million to settle a lawsuit that was brought by several Tennessee local governments and on behalf of a newborn child who was born addicted to opioids. The settlement agreements come after the drugmaker was accused of helping fuel the opioid epidemic that ravaged the nation over the past decade.
The lawsuit was brought on by nine counties and 18 cities and towns in northeast Tennessee. A third plaintiff known as “Baby Doe” was also listed in the complaint. The settlement, which has yet to be finalized, was reached the week before the case’s trial was set to begin.
This latest development with the case comes just months after a judge had ruled that Endo was liable for its role in the opioid epidemic that has swept the nation. The judgment was made without a civil trial taking place. This rare ruling was made by Sullivan County Circuit Court Chancellor E.G. Moody following what he described as a “coordinated strategy” on the part of Endo and its attorneys to delay the proceedings, keep records away from plaintiffs, and interfere with the judicial process. In the ruling, Moody wrote that Endo and its lawyers “have not shown any remorse, admitted their wrongdoing or apologized to opposing counsel or the Court for their actions.”
The District Attorney General Barry Staubus, who is also listed as a plaintiff in the case, explained of the ruling, “It’s very rare, but then again, rarely do you see the kind of behavior and actions taken by counsel and a defendant as outlined in that order.”
While the settlement is not yet finalized and requires several plaintiffs to agree to the terms, Endo shared in a statement that the settlement “will include no admission of wrongdoing, fault or liability of any kind by Endo, and the settlement value should not be extrapolated to any other opioid-related cases or claims.”
Gerard Stranch, a lawyer representing the plaintiffs in the case against Endo, shared that he anticipates that “all matters concerning participating cities and counties” will reach a conclusion by the end of the week.
Stranch also shared in a statement, “We are pleased that after four-plus years of litigation that we have been able to reach an agreement in principle with Endo, and are grateful to the communities of Northeast Tennessee for their support in this landmark prosecution.”
Along with Endo, Tennessee has filed suits against several companies regarding the opioid epidemic that has ravaged vulnerable parts of the nation, especially rural parts of Tennessee.
Meanwhile, on a national level, lawyers representing local governments shared in the same week that the potential value of a nationwide settlement associated with the opioid epidemic could reach up to $26 billion. The total number does depend on how many localities sign-on.
The settlement will involve the nation's three largest pharmaceutical companies including drugmaker Johnson & Johnson. Paul Geller, a lead lawyer representing local governments, shared in conference with reporters, “This is a nationwide crisis and it could have been and should have been addressed perhaps by other branches of government, but this really is an example of the use of litigation for fixing a national problem.” If this settlement is approved, it could potentially be the biggest settlement involving the nation’s biggest drugmakers.
Related Articles
The pharmaceutical giant Johnson & Johnson has agreed to pay $230 million in a settlement deal with New York state regarding the company’s role in the nation’s opioid crisis. The settlement will wrap up a 2019 lawsuit brought by New York Attorney General Letitia James which targets Johnson & Johnson... Read More »
In a landmark opioid case that began on Monday, brought by two counties and a city in West Virginia, attorneys for three gigantic drug manufacturers came out swinging, refusing to take any responsibility. Attorneys argued, in part, that their companies cannot be held responsible for the West Virginia opioid epidemic,... Read More »
A judge accepted Purdue Pharma’s bankruptcy claims on November 17, 2020 allowing the company to restructure and pay out their $8.3 billion settlement with the Department of Justice. Purdue Pharma developed the addictive opioid OxyContin in the 1990’s and has been mired in lawsuits ever since. The DOJ presented evidence... Read More »